The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host. (2018)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2018.04.015

PubMed Identifier: 29678552

Publication URI: http://europepmc.org/abstract/MED/29678552

Type: Journal Article/Review

Volume: 154

Parent Publication: Antiviral research

ISSN: 0166-3542